Cardiol Therapeutics (CRDL) Total Liabilities (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Total Liabilities came in at $5.3 million in Q1 2026, down 4.2% YoY from $5.5 million in Q1 2025, and up 27.56% on a QoQ basis from $4.1 million in Q4 2025.
Cardiol Therapeutics (CRDL) Total Liabilities (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Total Liabilities data on file, last reported at $5.3 million in Q1 2026.
- Quarterly Total Liabilities fell 4.2% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (down 4.2% YoY) and the FY2025 annual result came in at $4.1 million, down 19.38% from the prior year.
- Total Liabilities rose to $5.3 million in Q1 2026, from $4.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $9.0 million in Q2 2022 to a low of $2.5 million in Q3 2025.
- A 5-year average of $6.2 million and a median of $6.1 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 265.3% — and 2025, when it slumped 52.64%.
- Tracing CRDL's Total Liabilities over 5 years: stood at $7.2 million in 2022, then retreated by 14.22% to $6.2 million in 2023, then declined by 17.75% to $5.1 million in 2024, then slipped by 19.38% to $4.1 million in 2025, then climbed by 27.56% to $5.3 million in 2026.
- The last three Total Liabilities figures came in at $5.3 million (Q1 2026), $4.1 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 4.12 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 8.01 Mn |
| Mar 31, 2024 | 8.21 Mn |
| Dec 31, 2023 | 6.21 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Mar 31, 2023 | 5.27 Mn |
| Dec 31, 2022 | 7.24 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 8.95 Mn |
| Mar 31, 2022 | 8.07 Mn |
| Dec 31, 2021 | 9.23 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.45 Mn |